Adipose Tissue Transfer for Moderate Breast Cancer Conservative Treatment Sequella
Adipose Tissue Transfer for Moderate Breast Cancer Conservative Treatment Sequella
This is a phase III randomized multi-center study of equivalence comparing the radiological
 follow-up for patients benefiting from the correction of the esthetical relapse of the
 preservative treatment by fatty transfer compared with a simple supervision.

 It is planned that 440 patients participate in this study which plans to compare 2 groups of
 patients: a group of patients which will benefit from the surgical treatment by transfer of
 fatty tissue and a group of patients under simple supervision.

 follow-up consultations are planned in 10 in 45 days post-surgery then at 3 months, 6 months,
 12 months and 5 years to look for the expected unwanted effects in relation with the surgery
 but also to estimate the impact of the fatty transfer on the rate of local and\or from a
 distance relapse.

 During these consultations, the surgeon and the patient will also estimate the cosmetic
 result of the surgery thanks to a questionnaire of cosmetic evaluation and to standardized
 photos.
Inclusion Criteria:

 -  History of breast cancer treated by conservative surgery .

 -  Normal inclusion radiological assessment normal (ACR1 or ACR2)

 -  Moderate Deformations (Type I and II of the classification of Clough).

 -  Delay with regard to the end of the radiotherapy superior or equal to one-year-old.

 -  Moderated radio-dystrophies (< Grade 2 of the score LENT/SOMA).

 -  Signature of the informed consent

 -  Patient benefiting from social security

 -  Patient of more than 18 years old

 Exclusion Criteria:

 -  Abnormal radiological assessment (ACR3, ACR4 or ACR5)

 -  Absence of fatty excess .

 -  radio surgical relapses with vast fibroses of the breast (> Grade 2 of the score
 LENT/SOMA).

 -  Patient under 18 years old.

 -  administrative difficulties: impossibility to provide enlightened information to the
 patient, the refusal to sign the consent .

 -  pregnant women or breast feeding women

 -  patient under legal guardianship

 -  bilateral breast cancer regardless histologic type.